When: Tight range $112-116 for 2+ weeks with declining volume

Then: Small starter (≤10% of intended size) with stop at $110.70

When: Close >$122.32, >4M volume, MACD positive cross, RSI >50

Then: Fresh capital re-engagement becomes viable

HOLD; do not add new capital; use 110.70 trailing stop on existing exposure; wait for close above 120 on volume before reconsidering

• Death cross is genuine bearish setup: 50 SMA rolled over from 124.60 to 120.23 in six weeks; price is 7% below the 200 SMA; MACD at -2.00; price below all three major averages
• DUK peaked at 129.93 in early March and is at 113.84 in October — seven months of decline with hostile macro (10-Year Treasury at highest level since 2002; Polymarket pricing 96% no cuts in 2026)
• Free cash flow gap of -$4.48 billion annualized being funded by debt issuance; total debt at 92.21 billion (up from 88.45 billion YoY); net debt at 90.57 billion; debt-to-equity at 162%; interest expense roughly 3.8 billion annualized
• DUK yield of 3.75% versus 10-Year Treasury above 4.7% (possibly pushing 5%) — yield premium is now negative versus risk-free for first time in years
• Volatility coiling (Bollinger Bands at tightest in months) is directionally neutral; risk-reward skews down given death cross, 50 SMA slope, and MACD positioning; downside break of 111.05 targets 108 or lower
• Regulatory rate cases take 6-18 months while balance sheet deteriorates; every 100 basis points of incremental borrowing cost erodes earnings power
• PEG of 2.15 is fragile; "embedded growth" requires continuous debt issuance at reasonable rates — not guaranteed in higher-for-longer regime
• Actual risk-reward on first target (120) is roughly 2-to-1, not 3-to-1; stop-run slippage of 30-50 basis points brings realistic risk-reward to ~1.5-to-1

→ vs aggressive: Death cross with 50 SMA rolled over from 124.60 to 120.23 in six weeks and price 7% below 200 SMA is not a 'correction within a larger neutral context' — it's a downtrend where momentum has merely stopped accelerating, not reversed

→ vs aggressive: Mean reversion at month seven of a downtrend is catching a falling knife, not investing; the 10-Year Treasury at highest level since 2002 and 96% Polymarket odds of no cuts in 2026 create hostile conditions for utility multiple expansion

→ vs aggressive: Bollinger Band coiling is directionally neutral — the directional bias given 50 SMA slope, MACD at -2.00, death cross, and lower-band test is down, not up

→ vs aggressive: Regulatory rate cases take 6-18 months but the free cash flow gap is -$4.48 billion annualized NOW; balance sheet (92.21 billion debt, 162% D/E) deteriorates while waiting for PUC relief

→ vs aggressive: 3.75% yield versus 10-Year Treasury above 4.7% means DUK now trades at a yield discount to risk-free; income allocators are choosing Treasuries, creating real flow dynamics that pressure the stock

→ vs aggressive: PEG of 2.15 is not screaming value; 'contractually embedded growth' that requires continuous debt issuance at multi-decade high rates is fragile, not protected

→ vs aggressive: Quiet sentiment at multi-month lows means institutions have stepped aside, not that a vacuum awaits buying; absence of confirmation is reason to wait, not act

→ vs aggressive: Risk-reward is ~2-to-1 on first target (5.4% upside vs 2.75% downside), not 3-to-1; stop-run slippage of 30-50 basis points brings realistic risk-reward to ~1.5-to-1

HOLD core position; trim overweight via covered calls; tactical add up to 10% of intended size with stops at 110.70 on bounces to 116-118; reassess post-Q3 earnings

• DUK at 17x trailing earnings with 8% forward EPS growth on regulated franchise with 3.75% yield
• Coiled Bollinger Bands at multi-month lows indicate imminent volatility expansion (directionally agnostic)
• Q3 earnings in mid-to-late October is a defined binary catalyst resolving in 2-3 weeks
• Core position: maintain current weight unchanged
• Overweight trim: use relief bounces to 116-118 zone via covered calls at 120 strike (30-45 DTE)
• Covered call premium: 1-2% additional yield, lifting effective yield above 5% annualized
• New capital: up to 10% of intended position size (not 33% as aggressive analyst proposed)
• Tactical add stop: 110.70 (hard invalidation level for tactical layer is 111.05 close below with volume)
• Buy trigger for new capital: confirmed post-earnings reversal with rate base guidance intact OR 10-Year decline toward 4.4% OR credible Fed pivot breaking 96% no-cuts pricing
• Core invalidation is fundamentals-based (dividend coverage stress, regulatory setbacks, capex escalation without rate-base confirmation), not price-based
• Recommended position sizing: 4-6% in diversified utility/income sleeve, not 10% concentrated bet
• Negative free cash flow of negative 4.5 billion annually
• Debt up 4.3% year over year
• Total liabilities of 92 billion
• Regulated earnings mechanism adjusts to higher rates but with 6-18 month lag
• Multiple compression and refinancing risk have not fully played out
• Trend persistence makes downside resolution more likely than 50/50 on breakout (35/65 or 40/60 probability)
• Mean reversion thesis is a 12-24 month thesis, not a 4-8 week tactical thesis

→ vs aggressive: 25-33% scale-in is reckless and oversizes into uncertainty; this is a duration trade, not a momentum trade; 120 target requires three sequential resistance defeats (120, 122.37, 200-day MA) each with independent probability; rate case pass-through has 6-18 month lag; mean reversion is a 12-24 month thesis being compressed into tactical timeframe

→ vs conservative: Pure HOLD underutilizes the existing position and leaves option premium on the table; coiled Bollinger Bands and Q3 earnings catalyst deserve tactical response; pure waiting for technical confirmation costs first 3-5% of post-earnings move; covered call strategy captures income and reduces concentration simultaneously; dividend substitution effect is partial, not total, as dividend growth and tax-advantaged income buyers are distinct from yield-maximizers